Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population
NCT ID: NCT04322461
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2022-05-01
2024-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT01219647
Effects of Combined Physical-cognitive Training on Cognitive Function in MCI
NCT03805620
Reshaping the Path of Vascular Cognitive Impairment (VCI)
NCT02669394
Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)
NCT01219244
Exercise Training to Improve Cognitive Function
NCT03824639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson disease
2 months intervention with 50g/day of a commercial MCT supplement combine with supervised aerobic exercise 3x/week.
Betaquik MCT supplement
50g/day divided in 3. Breakfast, lunch and dinner
Alzheimer's disease
2 months intervention with 50g/day of a commercial MCT supplement combine with supervised aerobic exercise 3x/week.
Betaquik MCT supplement
50g/day divided in 3. Breakfast, lunch and dinner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Betaquik MCT supplement
50g/day divided in 3. Breakfast, lunch and dinner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable medication associated with the disease
* Able to consent
* Presence of an accompanying person for the first and last visit.
* Ability to read and talk in French
Exclusion Criteria
* MCT or coconut oil supplementation
* Coconut allergy
* Cannabis, THC or CBD consumption
* Excessive alcohol consumption
* Physical activity 3x/week
* Presence of an metallic object in the body
* Impossibility to lay in dorsal decubitus for 40 minutes
* Cardiac disease
* Any uncontrolled disease that could interfer with the project.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Cunnane, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de recherche sur le vieillissement
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-3436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.